2025 Bioelectronic Medicine Forum

New York Academy of Medicine, New York, NY, April 10, 2025

Tentative Agenda, All Times EDT

8:15-8:30

Welcome and Introductions

8:30-9:00

Overview of the Bioelectronic Medicine Industry

James Cavuoto, Editor, Neurotech Reports
BioElectRx Business Report Editor James Cavuoto presents an overview of the bioelectronic medicine industry, including key players, technological roots, and market projections.
9:00-9:30

Keynote Address

Lisa Shafer, Ph.D., Vice President, Product Development, Biogen
A pharmaceutical industry executive and medtech veteran offers their views on the future of bioelectronic medicine.
9:30-10:15

Investment in Bioelectronic Medicine

JoJo Platt, Senior Contributing Editor, Neurotech Reports, Moderator
Kevin Kotler, Managing Partner, Broadfin Capital
In this session, investment professionals active in the life sciences industry will offer their views on the investment climate for bioelectronic medicine.
10:15-10:45

Refreshment Break

10:45-11:30

Entrepreneur Panel I

James Cavuoto, Editor, Neurotech Reports, Moderator
Presentations from executives of emerging bioelectronic medicine firms.
11:30-12:15

Regulatory and Reimbursement Issues

James Cavuoto., Editor, Neurotech Reports, Moderator
David McMullen, M.D., Director, Office of Neurological and Physical Medicine Devices, FDA Center for Devices and Radiological Health (invited)
Nandan Lad, M.D., Ph.D., Vice Chair of Innovation, Duke Neurosurgery
Victor Pikov, Ph.D., Contributing Editor, BioElectRx Business Report
In this session, we'll look at recent developments in regulatory and reimbursement activity for biolelectronic medicine systems.
12:15-1:15

Luncheon

1:15-1:30

Luncheon Speaker

1:30-2:15

Bowel and Bladder Disorders

Jeremy Koff, Senior Consulting Editor, Neurotech Reports, Moderator
The market for neuromodulation therapies that treat disorders such as OAB changed dramatically with Boston Scientific's recent purchase of Axonics. In this session, we'll look at the competitive outlook in sacral nerve stimulation, tibial nerve stimulation, and other approaches.
2:15-3:00

Entrepreneur Panel II

JoJo Platt, Senior Contributing Editor, Neurotech Reports, Moderator
Presentations from executives of emerging bioelectronic medicine firms.
3:00-3:30

Refreshment Break

3:30-4:15

Entrepreneur Panel III

Jeremy Koff, Senior Consulting Editor, Neurotech Reports, Moderator
Presentations from executives of emerging bioelectronic medicine firms.
4:15-5:00

Respiratory Disorders

Victor Pikov, Ph.D., Contributing Editor, BioElectRx Business Report, Moderator
The neuromodulation market for treating disorders such as obstructive sleep apnea is one of the most promising segments of the bioelectronic emdicine industry. In this session, we'll look at the competitive outlook and opportunities for innovation.
5:00-6:30

Cocktail Reception